Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 22715389)

1.

Effector CD4+ T cell expression signatures and immune-mediated disease associated genes.

Zhang W, Ferguson J, Ng SM, Hui K, Goh G, Lin A, Esplugues E, Flavell RA, Abraham C, Zhao H, Cho JH.

PLoS One. 2012;7(6):e38510. doi: 10.1371/journal.pone.0038510. Epub 2012 Jun 8.

2.

Chemokines play a critical role in the cross-regulation of Th1 and Th17 immune responses in murine crescentic glomerulonephritis.

Paust HJ, Turner JE, Riedel JH, Disteldorf E, Peters A, Schmidt T, Krebs C, Velden J, Mittrücker HW, Steinmetz OM, Stahl RA, Panzer U.

Kidney Int. 2012 Jul;82(1):72-83. doi: 10.1038/ki.2012.101. Epub 2012 Apr 11.

PMID:
22495297
3.

IL-21 is a central memory T cell-associated cytokine that inhibits the generation of pathogenic Th1/17 effector cells.

Kastirr I, Maglie S, Paroni M, Alfen JS, Nizzoli G, Sugliano E, Crosti MC, Moro M, Steckel B, Steinfelder S, Stölzel K, Romagnani C, Botti F, Caprioli F, Pagani M, Abrignani S, Geginat J.

J Immunol. 2014 Oct 1;193(7):3322-31. doi: 10.4049/jimmunol.1400775. Epub 2014 Aug 29.

PMID:
25172491
4.

Differential expression of CD300a/c on human TH1 and TH17 cells.

Simhadri VR, Mariano JL, Zhou Q, DeBell KE, Borrego F.

BMC Immunol. 2011 Nov 2;12:62. doi: 10.1186/1471-2172-12-62.

5.

The Shc family protein adaptor, Rai, acts as a negative regulator of Th17 and Th1 cell development.

Savino MT, Ulivieri C, Emmi G, Prisco D, De Falco G, Ortensi B, Beccastrini E, Emmi L, Pelicci G, D'Elios MM, Baldari CT.

J Leukoc Biol. 2013 Apr;93(4):549-59. doi: 10.1189/jlb.0712331. Epub 2013 Jan 23.

6.

Chemokine receptors CCR6 and CXCR3 are necessary for CD4(+) T cell mediated ocular surface disease in experimental dry eye disease.

Coursey TG, Gandhi NB, Volpe EA, Pflugfelder SC, de Paiva CS.

PLoS One. 2013 Nov 4;8(11):e78508. doi: 10.1371/journal.pone.0078508. eCollection 2013.

7.

Combinatorial control of Th17 and Th1 cell functions by genetic variations in genes associated with the interleukin-23 signaling pathway in spondyloarthritis.

Coffre M, Roumier M, Rybczynska M, Sechet E, Law HK, Gossec L, Dougados M, Bianchi E, Rogge L.

Arthritis Rheum. 2013 Jun;65(6):1510-21. doi: 10.1002/art.37936.

8.

Genetic controls of Th17 cell differentiation and plasticity.

Dong C.

Exp Mol Med. 2011 Jan 31;43(1):1-6. Review.

9.

Distinctive features of classic and nonclassic (Th17 derived) human Th1 cells.

Maggi L, Santarlasci V, Capone M, Rossi MC, Querci V, Mazzoni A, Cimaz R, De Palma R, Liotta F, Maggi E, Romagnani S, Cosmi L, Annunziato F.

Eur J Immunol. 2012 Dec;42(12):3180-8. doi: 10.1002/eji.201242648. Epub 2012 Oct 25.

PMID:
22965818
10.

Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer.

Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, Bindea G, Berger A, Bruneval P, Fridman WH, Pagès F, Galon J.

Cancer Res. 2011 Feb 15;71(4):1263-71. doi: 10.1158/0008-5472.CAN-10-2907. Epub 2011 Feb 8. Erratum in: Cancer Res. 2011 Jul 1;71(13):4732.

11.

Increased Th17 differentiation in aged mice is significantly associated with high IL-1β level and low IL-2 expression.

Lim MA, Lee J, Park JS, Jhun JY, Moon YM, Cho ML, Kim HY.

Exp Gerontol. 2014 Jan;49:55-62. doi: 10.1016/j.exger.2013.10.006. Epub 2013 Oct 17.

13.

Reconstitution of interleukin-17-producing T helper cells after allogeneic hematopoietic cell transplantation.

Bahr F, Wehner R, Platzbecker U, Wermke M, Shayegi N, Middeke JM, Röllig C, Schetelig J, Ehninger G, Schmitz M, Bornhäuser M, Tuve S.

Biol Blood Marrow Transplant. 2013 Mar;19(3):357-65. doi: 10.1016/j.bbmt.2012.11.018. Epub 2012 Nov 30.

14.

Sarcoidosis is a Th1/Th17 multisystem disorder.

Facco M, Cabrelle A, Teramo A, Olivieri V, Gnoato M, Teolato S, Ave E, Gattazzo C, Fadini GP, Calabrese F, Semenzato G, Agostini C.

Thorax. 2011 Feb;66(2):144-50. doi: 10.1136/thx.2010.140319. Epub 2010 Dec 7.

PMID:
21139119
15.

The IL17A and IL17F loci have divergent histone modifications and are differentially regulated by prostaglandin E2 in Th17 cells.

Adamik J, Henkel M, Ray A, Auron PE, Duerr R, Barrie A.

Cytokine. 2013 Oct;64(1):404-12. doi: 10.1016/j.cyto.2013.05.010. Epub 2013 Jun 22.

16.

IL-25 downregulates Th1/Th17 immune response in an IL-10-dependent manner in inflammatory bowel disease.

Su J, Chen T, Ji XY, Liu C, Yadav PK, Wu R, Yang P, Liu Z.

Inflamm Bowel Dis. 2013 Mar-Apr;19(4):720-8. doi: 10.1097/MIB.0b013e3182802a76.

PMID:
23429464
17.

Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease.

Yi T, Chen Y, Wang L, Du G, Huang D, Zhao D, Johnston H, Young J, Todorov I, Umetsu DT, Chen L, Iwakura Y, Kandeel F, Forman S, Zeng D.

Blood. 2009 Oct 1;114(14):3101-12. doi: 10.1182/blood-2009-05-219402. Epub 2009 Jul 14.

18.

Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease.

Shimizu J, Takai K, Fujiwara N, Arimitsu N, Ueda Y, Wakisaka S, Yoshikawa H, Kaneko F, Suzuki T, Suzuki N.

Clin Exp Immunol. 2012 Apr;168(1):68-74. doi: 10.1111/j.1365-2249.2011.04543.x.

19.

IFN-γ and IL-12 synergize to convert in vivo generated Th17 into Th1/Th17 cells.

Lexberg MH, Taubner A, Albrecht I, Lepenies I, Richter A, Kamradt T, Radbruch A, Chang HD.

Eur J Immunol. 2010 Nov;40(11):3017-27. doi: 10.1002/eji.201040539.

PMID:
21061434
20.

Coronin 1A is an essential regulator of the TGFβ receptor/SMAD3 signaling pathway in Th17 CD4(+) T cells.

Kaminski S, Hermann-Kleiter N, Meisel M, Thuille N, Cronin S, Hara H, Fresser F, Penninger JM, Baier G.

J Autoimmun. 2011 Nov;37(3):198-208. doi: 10.1016/j.jaut.2011.05.018. Epub 2011 Jun 22.

PMID:
21700422
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk